Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Live Vaccinia Virus Vaccine [EPC]
Bovine Tuberculin is a purified protein derivative used primarily as a diagnostic tool for detecting Mycobacterium infections. It belongs to the allergenic extract and vaccine-related drug classes used to assess immune response.
Name
Bovine Tuberculin
Raw Name
BOVINE TUBERCULIN
Category
Live Vaccinia Virus Vaccine [EPC]
Drug Count
9
Variant Count
9
Last Verified
February 17, 2026
About Bovine Tuberculin
Bovine Tuberculin is a purified protein derivative used primarily as a diagnostic tool for detecting Mycobacterium infections. It belongs to the allergenic extract and vaccine-related drug classes used to assess immune response.
Detailed information about Bovine Tuberculin
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Bovine Tuberculin.
Bovine Tuberculin, specifically the Purified Protein Derivative (PPD) derived from Mycobacterium bovis, is a sterile fraction of the soluble growth products of the tubercle bacillus. In clinical and veterinary medicine, it serves as the gold-standard diagnostic antigen for detecting sensitization to mycobacteria. According to the FDA-approved labeling and historical regulatory frameworks, Bovine Tuberculin is categorized under several Established Pharmacologic Classes (EPC), including Live Vaccinia Virus Vaccine [EPC] and Non-Standardized Allergenic Extracts. While it is not a vaccine in the sense of providing active immunity, its classification reflects its biological origin and its role in stimulating an immune-mediated response for diagnostic purposes.
Historically, the development of tuberculin dates back to Robert Koch in 1890, though the modern Purified Protein Derivative (PPD) was refined by Florence Seibert in the 1930s. The bovine variant is specifically prepared from the culture filtrate of M. bovis that has been heat-killed, filtered, and chemically precipitated. This process ensures that the final product contains the essential tuberculoproteins required to elicit a delayed-type hypersensitivity (DTH) reaction without the risk of causing an active infection. Healthcare providers utilize this agent to identify individuals or livestock that have been exposed to tuberculosis, facilitating early intervention and public health management.
Bovine Tuberculin functions through a complex immunological mechanism known as a Type IV Hypersensitivity reaction, or delayed-type hypersensitivity (DTH). When a small amount of the antigen is injected intradermally (into the skin), it interacts with sensitized T-lymphocytes in individuals previously exposed to Mycobacterium bovis or Mycobacterium tuberculosis.
At the molecular level, the proteins in Bovine Tuberculin are recognized by antigen-presenting cells (APCs), such as macrophages and dendritic cells. These cells process the proteins and present them to memory T-cells. If the individual has been previously sensitized, these T-cells become activated and release a cascade of pro-inflammatory cytokines, including Interferon-gamma (IFN-γ), Tumor Necrosis Factor-alpha (TNF-α), and various interleukins. This cytokine release recruits additional inflammatory cells to the site of injection over a period of 24 to 72 hours. The resulting clinical manifestation is an induration (a hard, raised area of skin), which is measured to determine the presence of infection. It is important to note that this test measures immune memory rather than the presence of active disease.
Unlike therapeutic medications, Bovine Tuberculin is a diagnostic biological agent administered locally, and its systemic pharmacokinetic profile is not the primary focus of its clinical utility. However, its behavior within the tissue is well-documented:
Bovine Tuberculin is primarily indicated for the following:
Bovine Tuberculin is typically available as:
> Important: Only your healthcare provider can determine if Bovine Tuberculin is right for your specific condition or screening requirements. The interpretation of results requires professional training to distinguish between true positive reactions and cross-reactivity.
The standard adult dosage for the tuberculin skin test (TST) using Bovine Tuberculin is 0.1 mL of the purified protein derivative. This volume typically contains 5 Tuberculin Units (TU). The dose is standardized to ensure that the resulting induration can be accurately compared against established diagnostic thresholds. For diagnostic purposes, the dose is always administered via the Mantoux technique, which involves a precise intradermal injection. Dosing does not vary based on body weight or age in the adult population, as the goal is to elicit a localized immune response rather than achieve a systemic therapeutic concentration.
Bovine Tuberculin is approved for use in pediatric populations, including infants. The dosage remains the same as the adult dose: 0.1 mL (5 TU) administered intradermally. Pediatric screening is a critical component of public health, especially for children who have been in close contact with individuals with active tuberculosis. Healthcare providers must exercise care during administration to ensure the injection is truly intradermal, as subcutaneous administration can lead to false-negative results.
No dosage adjustments are required for patients with renal impairment. Because the product is administered locally and systemic absorption is negligible, the clearance of the antigen is not significantly affected by kidney function.
No dosage adjustments are necessary for patients with hepatic impairment. The metabolism of Bovine Tuberculin proteins occurs primarily at the site of injection and through the lymphatic system, bypassing the need for hepatic processing.
While the dose remains 0.1 mL, the interpretation of the test in elderly patients may require special consideration. The immune response can wane with age (immunosenescence), potentially leading to false-negative results. In some cases, a 'two-step' testing procedure is used to 'boost' a dormant immune response, where a second test is administered 1-3 weeks after an initial negative result.
Bovine Tuberculin must be administered by a trained healthcare professional. It is not for self-administration. The following steps are typical:
As Bovine Tuberculin is a one-time diagnostic test rather than a daily medication, a 'missed dose' refers to a failure to have the test site read by a professional within the required 48- to 72-hour window. If the patient does not return for a reading within 72 hours, the test is considered invalid and must be repeated. The repeat test can usually be performed immediately, but it should be administered on a different arm or at least 2 inches away from the original site.
Systemic overdose is extremely unlikely given the small volume (0.1 mL) used. However, an 'overdose' in the form of a hyper-reactive local response can occur in highly sensitized individuals. Signs of a severe local reaction include intense swelling, blistering (vesiculation), or tissue death (necrosis) at the injection site. In such cases, the area should be kept clean and dry, and the patient should be monitored for signs of systemic anaphylaxis, which requires emergency medical intervention.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or attempt to interpret the skin reaction without medical guidance.
The most frequent side effects of Bovine Tuberculin are localized to the injection site and are actually expected components of a positive diagnostic reaction. These include:
> Warning: Stop the procedure and call your doctor immediately or seek emergency care if you experience any of these symptoms of a systemic allergic reaction:
Bovine Tuberculin does not typically cause long-term side effects because it is not a chronic medication. However, in cases of severe local reactions (necrosis or deep ulceration), permanent scarring or hyperpigmentation at the injection site may occur. There is no evidence that Bovine Tuberculin causes long-term changes to the immune system or increases the risk of developing autoimmune disorders.
No FDA black box warnings are currently issued for Bovine Tuberculin. However, the manufacturer's labeling emphasizes that the product must never be administered to individuals who have previously experienced a severe necrotic reaction to tuberculin, as this can lead to significant local tissue damage.
Report any unusual symptoms or severe skin reactions to your healthcare provider immediately. If a blister or sore forms, do not cover it with a tight bandage or apply ointments unless directed by a physician.
Bovine Tuberculin is a diagnostic tool and must be handled with the same precautions as any biological product. The most critical safety consideration is the risk of a severe local or systemic allergic reaction. Healthcare facilities must be equipped with epinephrine (1:1000) and other emergency resuscitative equipment whenever Bovine Tuberculin is administered. Patients should be observed for at least 15 to 20 minutes following the injection to monitor for immediate hypersensitivity reactions.
No FDA black box warnings for Bovine Tuberculin. The product is considered safe for its intended diagnostic use when administered by trained professionals according to standardized protocols.
No routine laboratory tests (like blood counts or liver function tests) are required for the administration of Bovine Tuberculin. The primary 'monitoring' is the physical examination of the injection site 48 to 72 hours after administration. The healthcare provider must measure the diameter of the induration (not the redness) in millimeters using a standardized ruler.
Bovine Tuberculin does not typically affect the ability to drive or operate machinery. However, if a patient experiences dizziness or a vasovagal response (fainting) following the injection, they should wait until symptoms fully resolve before attempting these activities.
There are no known direct interactions between alcohol and Bovine Tuberculin. However, excessive alcohol consumption can suppress the immune system, which might theoretically interfere with the development of a robust delayed-type hypersensitivity reaction. It is generally advisable to avoid heavy drinking during the 72-hour window between injection and reading.
As Bovine Tuberculin is a single-dose diagnostic test, 'discontinuation' is not applicable in the traditional sense. Once the antigen is injected, the process cannot be stopped. If a patient decides they no longer want the test after the injection has occurred, the only course of action is to ignore the results, though the local reaction will still occur naturally.
> Important: Discuss all your medical conditions, especially any history of severe skin reactions or immune system disorders, with your healthcare provider before starting Bovine Tuberculin.
There are no absolute drug-drug contraindications that would result in a fatal interaction; however, certain combinations are clinically avoided because they render the diagnostic test useless.
There are no documented food interactions with Bovine Tuberculin. Dietary choices do not affect the localized T-cell response required for the Mantoux test.
Bovine Tuberculin does not interfere with standard blood chemistry or hematology tests. However, it will interfere with subsequent tuberculin skin tests if performed too frequently (the 'booster effect'). It does not interfere with the Interferon-Gamma Release Assay (IGRA) blood test if the blood is drawn at the time of the TST or shortly thereafter.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially those that affect your immune system.
Bovine Tuberculin must NEVER be used in the following circumstances:
Patients who are sensitive to Human Tuberculin (PPD-S) will also be sensitive to Bovine Tuberculin due to the high degree of protein homology between M. tuberculosis and M. bovis. There is also potential cross-sensitivity with the BCG vaccine, which is derived from an attenuated strain of M. bovis.
> Important: Your healthcare provider will evaluate your complete medical history, including previous skin test results, before prescribing Bovine Tuberculin.
Bovine Tuberculin is generally considered safe for use during pregnancy. According to the CDC and American Thoracic Society, pregnancy does not interfere with the TST result, and the test is not known to pose a risk to the developing fetus. There is no evidence of teratogenicity. Screening is particularly important for pregnant women in high-risk groups, as active tuberculosis poses a significant threat to both the mother and the infant. The benefits of identifying a latent TB infection far outweigh the minimal risks of the diagnostic procedure.
There are no known contraindications to using Bovine Tuberculin while breastfeeding. The tuberculoproteins are administered locally in a very small dose and do not pass into breast milk in any quantity that would affect a nursing infant. Breastfeeding mothers can safely undergo TB screening without interrupting their nursing schedule.
Bovine Tuberculin is safe and effective for use in children of all ages. In fact, the TST is a primary method for TB screening in pediatric populations. Healthcare providers should be aware that children under the age of 5 may have a higher risk of progressing from latent infection to active disease, making accurate testing and interpretation vital. In children who have received the BCG vaccine, a positive TST result may be difficult to interpret, and an IGRA blood test may be considered as an alternative in children 2 years and older.
In patients over the age of 65, the immune system's ability to react to the tuberculin antigen may diminish. This can lead to a 'false negative' where the patient is actually infected but doesn't show a reaction. To address this, a 'two-step' test is often used in long-term care facilities. If the first test is negative, a second test is given 1 to 3 weeks later. The first test 'reminds' the immune system of the antigen, and the second test provides a more accurate reading.
No special precautions are needed for patients with kidney disease. The local nature of the test means that renal clearance is not a factor in the safety or efficacy of Bovine Tuberculin.
Patients with liver disease can safely receive Bovine Tuberculin. There is no evidence that hepatic dysfunction alters the T-cell mediated response required for a successful Mantoux test.
> Important: Special populations require individualized medical assessment to ensure that diagnostic results are interpreted correctly within the context of their overall health.
Bovine Tuberculin acts as an exogenous antigen that triggers a delayed-type hypersensitivity (DTH) reaction. It specifically targets memory T-lymphocytes (CD4+ T-cells). Upon intradermal injection, the proteins are captured by Langerhans cells in the epidermis and transported to local lymph nodes. If the individual has been previously exposed to Mycobacterium bovis or M. tuberculosis, these memory T-cells recognize the antigen and migrate back to the injection site. There, they release cytokines (IFN-γ, IL-2) that increase vascular permeability and recruit macrophages, leading to the characteristic firm swelling (induration).
| Parameter | Value |
|---|---|
| Bioavailability | Localized (Intradermal) |
| Protein Binding | N/A (Local tissue interaction) |
| Half-life | ~24-48 hours (at injection site) |
| Tmax | 48-72 hours (for clinical effect) |
| Metabolism | Local Proteolysis |
| Excretion | Lymphatic clearance |
Bovine Tuberculin is a complex mixture of proteins, lipids, and polysaccharides derived from Mycobacterium bovis. The Purified Protein Derivative (PPD) is obtained by precipitation with trichloroacetic acid or ammonium sulfate. It is soluble in water and typically buffered with phosphates and stabilized with Tween 80 (polysorbate 80) to prevent the proteins from sticking to the glass vial or plastic syringe. The molecular weight of the active proteins ranges from 10,000 to 40,000 Daltons.
Bovine Tuberculin is classified as an Allergenic Extract and a Diagnostic Antigen. Within the FDA's Established Pharmacologic Class (EPC) system, it is grouped with other biologicals like the Live Vaccinia Virus Vaccine due to its origin from live cultures, although it contains no live organisms in its final form.
Medications containing this ingredient
Common questions about Bovine Tuberculin
Bovine Tuberculin is primarily used as a diagnostic tool to detect whether a person or animal has been infected with the bacteria that cause tuberculosis (TB). It is administered through a skin test known as the Mantoux test, where a small amount of the liquid is injected just under the surface of the skin on the forearm. If the body's immune system recognizes the proteins in the tuberculin, a raised, hard bump will develop at the injection site within two to three days. This test is essential for screening individuals who have been exposed to TB or those who work in high-risk environments like healthcare. It helps identify 'latent' TB, where the person is infected but not yet sick, allowing for preventative treatment.
The most common side effects are localized to the area where the injection was given and are usually mild. These include redness, itching, and a feeling of tenderness or soreness that typically lasts for a few days. In some cases, a small bruise may appear at the site, which is generally harmless and does not affect the test result. A positive reaction itself involves a hard, raised area of skin (induration), which is the intended result of the test in infected individuals. Most of these local symptoms resolve on their own without treatment within a week. If you experience severe pain or widespread hives, you should contact your healthcare provider immediately.
There is no direct chemical interaction between alcohol and Bovine Tuberculin that would cause a dangerous reaction. However, healthcare providers generally recommend avoiding heavy alcohol consumption between the time the test is administered and when it is read (48 to 72 hours later). This is because alcohol can affect the immune system's inflammatory response, which might theoretically interfere with the accuracy of the skin reaction. Additionally, alcohol can cause skin flushing or dehydration, which might make the injection site harder to evaluate. For the most accurate diagnostic result, it is best to maintain your normal health status during the testing window. Always follow any specific instructions provided by your clinic.
Yes, Bovine Tuberculin is considered safe for use during all stages of pregnancy. Medical organizations like the CDC state that the skin test is both valid and safe for pregnant women, as the injection is local and does not pose a risk to the developing fetus. Tuberculosis can be very dangerous for both a mother and her baby, so screening is often recommended if there is a risk of exposure. There is no evidence that the test causes birth defects or pregnancy complications. If you are pregnant and require a TB test, you should proceed as directed by your doctor. Always inform your healthcare provider that you are pregnant before any medical procedure.
Bovine Tuberculin works through a delayed immune response, meaning the results are not visible immediately. After the injection is given, you must wait between 48 and 72 hours for the reaction to fully develop. During this time, the body's T-cells travel to the injection site if they recognize the TB proteins. If you check the site too early (before 48 hours) or too late (after 72 hours), the reading may be inaccurate and the test might need to be repeated. It is crucial to keep your follow-up appointment so a trained professional can measure the reaction. Do not attempt to measure or interpret the bump yourself.
Since Bovine Tuberculin is a single-dose diagnostic injection and not a continuous medication, the concept of 'stopping' the drug does not apply. Once the 0.1 mL dose is injected under your skin, the biological process of the test begins and cannot be reversed. You do not need to take any further doses or follow-up medications unless the test result is positive and your doctor prescribes TB treatment. If you decide you do not want to know the results after the injection has been given, you simply would not return for the reading, though the local skin reaction will still occur. There are no withdrawal symptoms associated with this diagnostic agent.
A 'missed dose' in the context of Bovine Tuberculin usually means you missed the 48-to-72-hour window for having your skin reaction read by a professional. If you do not return to the clinic within 72 hours, the test result is no longer valid and cannot be used for a diagnosis. In this situation, you will likely need to have the test repeated. Your healthcare provider will usually wait at least one week before re-administering the test, often using the other arm. It is important to schedule the repeat test as soon as possible to ensure you are properly screened for tuberculosis. Always set a reminder for your reading appointment to avoid this inconvenience.
No, Bovine Tuberculin does not cause weight gain. It is a one-time diagnostic injection containing a very small amount of protein (only 0.1 mL of liquid). It does not contain hormones, calories, or any substances that affect metabolism or appetite. Any changes in weight you experience would be unrelated to the tuberculin skin test. If you are experiencing unexplained weight changes, you should discuss them with your doctor, as weight loss (not gain) is actually a common symptom of active tuberculosis infection. The test itself is purely for diagnostic purposes and has no systemic metabolic effects.
Bovine Tuberculin can be administered while you are taking most medications, but some drugs can interfere with the test's accuracy. Specifically, immunosuppressants like high-dose steroids (prednisone) or chemotherapy can weaken your immune response, potentially leading to a false-negative result. Also, if you have recently received a live virus vaccine (like the MMR or chickenpox vaccine), you should wait 4 to 6 weeks before getting a TB skin test. It is important to provide your healthcare provider with a full list of your current medications and recent vaccinations. They will determine if the timing is right for an accurate test result.
Bovine Tuberculin is a biological product rather than a simple chemical drug, so it is not referred to as a 'generic' in the traditional sense. Instead, there are different brands and manufacturers of Purified Protein Derivative (PPD) that are considered clinically equivalent. In the United States, common brands include Tubersol and Aplisol, which are standardized to the same potency. While the specific source (human vs. bovine strains) may vary depending on the country and the specific diagnostic use (human medicine vs. veterinary medicine), the 5 TU (Tuberculin Unit) strength is the standard for human testing. Your insurance or clinic will typically provide whichever brand is currently in their stock.